Wednesday, October 14, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 18, 2026

The Nasdaq Just Did Something It Hasn't Done Since 2020, and Here's What Could Happen Next

View original at nasdaq.com
The Nasdaq Just Did Something It Hasn't Done Since 2020, and Here's What Could Happen Next Key Points The stock market recently declined on the back of soaring oil prices, triggered by the conflict between the U.S…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • If OpenAI and other top developers plan to spend less money on development, then Oracle and Microsoft will have to pull back on their infrastructure spending

    60% confidence
  • Time in the market always beats timing the market, so waiting on the sidelines for a better opportunity will often result in missed gains instead

    60% confidence
  • The index recently logged the largest 13-day gain since 2020, but the potential risks surrounding the AI industry haven't subsided

    60% confidence
  • The 10 best stocks for investors to buy now could produce monster returns in the coming years

    60% confidence
  • The Nasdaq-100 technology index was already slipping prior to the war, as concerns mounted about the sustainability of the artificial intelligence (AI) spending boom

    60% confidence
  • The stock market recently declined on the back of soaring oil prices, triggered by the conflict between the U.S. and Iran

    60% confidence
  • History suggests the Nasdaq-100 will continue to rise over the long-term

    60% confidence
  • Investors might have already priced in a slowdown

    60% confidence
  • The knock-on effects will result in less revenue for suppliers of data center chips and networking components like Nvidia, Advanced Micro Devices, Broadcom, and Micron Technology

    60% confidence

Data points we hold from this source

OpenAI · capital expenditure previous estimate1400 USD
OpenAI · capital expenditure target600 USD
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com
The Nasdaq Just Did Something It Hasn't Done Since 2020, and Here's What Could Happen Next — Source | Via News | Finance Via News